Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 138 results for "Tecfidera Treated Patients"

Oral MS treatment Tecfidera commissioned in Northern Ireland

Tecfidera (dimethyl fumarate) has been approved for use for people with relapsing remitting MS in Northern Ireland. The Northern Ireland Health and Social Care Board has now issued a service notification for the treatment. This means that ... Multiple Sclerosis Society, 2 weeks ago

New oral treatment for multiple sclerosis approved for use in Canada

Linda Hoang, CTV Edmonton Published Tuesday, May 7, 2013 4:07PM MDT Last Updated Tuesday, May 7, 2013 6:06PM MDT A new oral treatment for those living with multiple sclerosis has been approved for use in Canada. Tecfidera is an oral ...
 CTV News6 days ago

Neuroscience Treatments To Watch

This article is a companion piece to Brain Boom: The Drug Companies Bringing Neuroscience Back From The Brink . Breakthroughs in genetics and sheer stubbornness on the part of drug developers could soon lead to new drugs for intractable brain ...
 Forbes.com2 weeks ago

Biogen Idec Inc Earnings: Worth the Wait

Going into the release, there was worry that growth of Tecfidera, Biogen's oral multiple sclerosis drug, was slowing down, especially in the U.S., but that doesn't really seem to be as big of a problem as investors feared. There was one extra ...
 Motley Fool1 month ago
Boston Globe

Biogen drug for multiple sclerosis shows promise in repairing eye nerve damage

Biogen Idec Inc.'s experimental drug for multiple sclerosis showed signs that it could help repair nerve damage in patients eyes, a tentatively positive step for a drug aimed at reversing progression of the disease. In a mid-stage trial of 82 ...
 Boston Globe1 month ago Biogen MS Drug Shows Some Promise in Repairing Eye Nerve Damage  BusinessWeek1 month ago

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 2, Authorised

This is a summary of the European public assessment report (EPAR) for Tecfidera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on ...
 European Medicines Agency2 months ago
Motley Fool

3 Large Cap Biotech Stocks That Could Surprise Investors in 2015

Source: Celgene Corp. The volatility that comes with investing in biotech stocks can test the patience of even the most risk-tolerant investor. Many investors may be better served focusing on companies with proven track records of success rather ...
 Motley Fool2 months ago

BIOGEN IDEC : 2014 Revenues Increase 40% to $9.7 Billion

Performance led by continued growth in MS portfolio Four new treatments launched, including two in hemophilia, a new therapeutic area Pipeline programs advance in Multiple Sclerosis, Spinal Muscular Atrophy, and Alzheimer's ...
 4 Traders1 month ago Biogen Idec 2014 Revenues Increase 40% to $9.7 Billion  Enhanced Online News1 month ago 5 Reasons I Am Not Adding Biogen Idec To My Healthcare Portfolio  Seeking Alpha1 week ago
[x]  
Citybizlist

Why Biogen Idec Inc. Stock Catapulted 10% Higher in December

What: Shares of Biogen Idec (NASDAQ: BIIB ) , a biotech juggernaut primarily focused on treating multiple sclerosis and autoimmune disorders, scorched higher by 10% in December, based on data from S&P Capital IQ , on the heels of positive clinical ...
 Citybizlist1 month ago Biogen Idec expands North Carolina manufacturing operations  FiercePharmaManufacturing3 weeks ago
Reuters UK

Biogen shares fall after optic nerve study results seen as mixed

(Reuters) - Biogen Idec Inc said an experimental drug showed evidence of biological repair of the optic nerve in patients with acute inflammation of the optic nerve, but shares fell as analysts wondered how promising the mid-stage study results ...
 Reuters UK1 month ago Biogen Idec's Critical Nerve Repair Drug is Poised for Big News -- Soon  TheStreet.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less